Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Kidney International|July 17, 2009
Nephrology in the Netherlands is not going underPieter M Ter Wee
Nature Clinical Practice. Nephrology|October 25, 2007
The new peritoneal dialysis solutions: friends only, or foes in part?Pieter M ter Wee, Frans J van Ittersum
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 11, 2006
Peritoneal dialysis-related infections recommendations 2005--an important tool for quality improvementElisabeth W Boeschoten, Pieter M Ter Wee, Jose Divino
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 19, 2017
Improved Outcome of Enteric Peritonitis in Peritoneal Dialysis Patients Aged 50 Years and Older with Temporary Discontinuation of Peritoneal Dialysis and Intravenous MeropenemAlferso C Abrahams, Wim Rüger, Pieter M Ter Wee, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|June 19, 2010
Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitisWim Rüger, Frans J van Ittersum, Luiz F Comazzetto, et al.
Sleep Medicine|July 15, 2009
Different melatonin rhythms and sleep-wake rhythms in patients on peritoneal dialysis, daytime hemodialysis and nocturnal hemodialysisBirgit C P Koch, J Elsbeth Nagtegaal, E Christiaan Hagen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 15, 2013
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: part 2: renal replacement therapyAchim Jörres, Stefan John, Andrew Lewington, et al.
Clinical Kidney Journal|October 5, 2019
Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3Annet Bouma-de Krijger, Frans J van Ittersum, Tiny Hoekstra, et al.
Nephron|July 22, 2016
Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT)Aaltje Y Adema, Maarten A de Jong, Martin H de Borst, et al.
Blood Purification|August 19, 2007
Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective studyS Azam Nurmohamed, Marc G Vervloet, Armand R J Girbes, et al.
Pageof 4